Cargando…

Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs

BACKGROUND: Assessing the long term effects of many surgical interventions tested in pragmatic RCTs may require extended periods of participant follow-up to assess effectiveness and use patient-reported outcomes that require large sample sizes. Consequently the RCTs are often perceived as being expe...

Descripción completa

Detalles Bibliográficos
Autores principales: Parsons, Nick R., Stallard, Nigel, Parsons, Helen, Haque, Aminul, Underwood, Martin, Mason, James, Khan, Iftekhar, Costa, Matthew L., Griffin, Damian R., Griffin, James, Beard, David J., Cook, Jonathan A., Davies, Loretta, Hudson, Jemma, Metcalfe, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526271/
https://www.ncbi.nlm.nih.gov/pubmed/36183085
http://dx.doi.org/10.1186/s12874-022-01734-2
_version_ 1784800842278240256
author Parsons, Nick R.
Stallard, Nigel
Parsons, Helen
Haque, Aminul
Underwood, Martin
Mason, James
Khan, Iftekhar
Costa, Matthew L.
Griffin, Damian R.
Griffin, James
Beard, David J.
Cook, Jonathan A.
Davies, Loretta
Hudson, Jemma
Metcalfe, Andrew
author_facet Parsons, Nick R.
Stallard, Nigel
Parsons, Helen
Haque, Aminul
Underwood, Martin
Mason, James
Khan, Iftekhar
Costa, Matthew L.
Griffin, Damian R.
Griffin, James
Beard, David J.
Cook, Jonathan A.
Davies, Loretta
Hudson, Jemma
Metcalfe, Andrew
author_sort Parsons, Nick R.
collection PubMed
description BACKGROUND: Assessing the long term effects of many surgical interventions tested in pragmatic RCTs may require extended periods of participant follow-up to assess effectiveness and use patient-reported outcomes that require large sample sizes. Consequently the RCTs are often perceived as being expensive and time-consuming, particularly if the results show the test intervention is not effective. Adaptive, and particularly group sequential, designs have great potential to improve the efficiency and cost of testing new and existing surgical interventions. As a means to assess the potential utility of group sequential designs, we re-analyse data from a number of recent high-profile RCTs and assess whether using such a design would have caused the trial to stop early. METHODS: Many pragmatic RCTs monitor participants at a number of occasions (e.g. at 6, 12 and 24 months after surgery) during follow-up as a means to assess recovery and also to keep participants engaged with the trial process. Conventionally one of the outcomes is selected as the primary (final) outcome, for clinical reasons, with others designated as either early or late outcomes. In such settings, novel group sequential designs that use data from not only the final outcome but also from early outcomes at interim analyses can be used to inform stopping decisions. We describe data from seven recent surgical RCTs (WAT, DRAFFT, WOLLF, FASHION, CSAW, FIXDT, TOPKAT), and outline possible group sequential designs that could plausibly have been proposed at the design stage. We then simulate how these group sequential designs could have proceeded, by using the observed data and dates to replicate how information could have accumulated and decisions been made for each RCT. RESULTS: The results of the simulated group sequential designs showed that for two of the RCTs it was highly likely that they would have stopped for futility at interim analyses, potentially saving considerable time (15 and 23 months) and costs and avoiding patients being exposed to interventions that were either ineffective or no better than standard care. We discuss the characteristics of RCTs that are important in order to use the methodology we describe, particularly the value of early outcomes and the window of opportunity when early stopping decisions can be made and how it is related to the length of recruitment period and follow-up. CONCLUSIONS: The results for five of the RCTs tested showed that group sequential designs using early outcome data would have been feasible and likely to provide designs that were at least as efficient, and possibly more efficient, than the original fixed sample size designs. In general, the amount of information provided by the early outcomes was surprisingly large, due to the strength of correlations with the primary outcome. This suggests that the methods described here are likely to provide benefits more generally across the range of surgical trials and more widely in other application areas where trial designs, outcomes and follow-up patterns are structured and behave similarly. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-022-01734-2.
format Online
Article
Text
id pubmed-9526271
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95262712022-10-02 Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs Parsons, Nick R. Stallard, Nigel Parsons, Helen Haque, Aminul Underwood, Martin Mason, James Khan, Iftekhar Costa, Matthew L. Griffin, Damian R. Griffin, James Beard, David J. Cook, Jonathan A. Davies, Loretta Hudson, Jemma Metcalfe, Andrew BMC Med Res Methodol Research BACKGROUND: Assessing the long term effects of many surgical interventions tested in pragmatic RCTs may require extended periods of participant follow-up to assess effectiveness and use patient-reported outcomes that require large sample sizes. Consequently the RCTs are often perceived as being expensive and time-consuming, particularly if the results show the test intervention is not effective. Adaptive, and particularly group sequential, designs have great potential to improve the efficiency and cost of testing new and existing surgical interventions. As a means to assess the potential utility of group sequential designs, we re-analyse data from a number of recent high-profile RCTs and assess whether using such a design would have caused the trial to stop early. METHODS: Many pragmatic RCTs monitor participants at a number of occasions (e.g. at 6, 12 and 24 months after surgery) during follow-up as a means to assess recovery and also to keep participants engaged with the trial process. Conventionally one of the outcomes is selected as the primary (final) outcome, for clinical reasons, with others designated as either early or late outcomes. In such settings, novel group sequential designs that use data from not only the final outcome but also from early outcomes at interim analyses can be used to inform stopping decisions. We describe data from seven recent surgical RCTs (WAT, DRAFFT, WOLLF, FASHION, CSAW, FIXDT, TOPKAT), and outline possible group sequential designs that could plausibly have been proposed at the design stage. We then simulate how these group sequential designs could have proceeded, by using the observed data and dates to replicate how information could have accumulated and decisions been made for each RCT. RESULTS: The results of the simulated group sequential designs showed that for two of the RCTs it was highly likely that they would have stopped for futility at interim analyses, potentially saving considerable time (15 and 23 months) and costs and avoiding patients being exposed to interventions that were either ineffective or no better than standard care. We discuss the characteristics of RCTs that are important in order to use the methodology we describe, particularly the value of early outcomes and the window of opportunity when early stopping decisions can be made and how it is related to the length of recruitment period and follow-up. CONCLUSIONS: The results for five of the RCTs tested showed that group sequential designs using early outcome data would have been feasible and likely to provide designs that were at least as efficient, and possibly more efficient, than the original fixed sample size designs. In general, the amount of information provided by the early outcomes was surprisingly large, due to the strength of correlations with the primary outcome. This suggests that the methods described here are likely to provide benefits more generally across the range of surgical trials and more widely in other application areas where trial designs, outcomes and follow-up patterns are structured and behave similarly. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12874-022-01734-2. BioMed Central 2022-10-01 /pmc/articles/PMC9526271/ /pubmed/36183085 http://dx.doi.org/10.1186/s12874-022-01734-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Parsons, Nick R.
Stallard, Nigel
Parsons, Helen
Haque, Aminul
Underwood, Martin
Mason, James
Khan, Iftekhar
Costa, Matthew L.
Griffin, Damian R.
Griffin, James
Beard, David J.
Cook, Jonathan A.
Davies, Loretta
Hudson, Jemma
Metcalfe, Andrew
Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
title Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
title_full Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
title_fullStr Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
title_full_unstemmed Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
title_short Group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical RCTs
title_sort group sequential designs in pragmatic trials: feasibility and assessment of utility using data from a number of recent surgical rcts
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9526271/
https://www.ncbi.nlm.nih.gov/pubmed/36183085
http://dx.doi.org/10.1186/s12874-022-01734-2
work_keys_str_mv AT parsonsnickr groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT stallardnigel groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT parsonshelen groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT haqueaminul groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT underwoodmartin groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT masonjames groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT khaniftekhar groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT costamatthewl groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT griffindamianr groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT griffinjames groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT bearddavidj groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT cookjonathana groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT daviesloretta groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT hudsonjemma groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts
AT metcalfeandrew groupsequentialdesignsinpragmatictrialsfeasibilityandassessmentofutilityusingdatafromanumberofrecentsurgicalrcts